ArticleContemporary oncology (Poznan, Poland)2020

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy.

Bożena Cybulska-Stopa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.